FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135991329> ?p ?o ?g. }

• W2135991329 abstract "The dietary agent sulforaphane (SFN) has been reported to induce nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2)-dependent pathways as well as inhibiting histone deacetylase (HDAC) activity. The current investigation sought to examine the relationships between Nrf2 status and HDAC expression in preclinical and translational studies.Wild type (WT) and Nrf2-deficient (Nrf2(-/+)) mice were treated with the colon carcinogen 1,2-dimethylhydrazine (DMH) followed by 400 ppm SFN in the diet (n = 35 mice/group). WT mice were more susceptible than Nrf2(-/+) mice to tumor induction in the colon. Tumors from WT mice had higher HDAC levels globally and locally on genes such as cyclin-dependant kinase inhibitor 2a (Cdkn2a/p16) that were dysregulated during tumor development. The average tumor burden was reduced by SFN from 62.7 to 26.0 mm(3) in WT mice and from 14.6 to 11.7 mm(3) in Nrf2(-/+) mice. The decreased antitumor activity of SFN in Nrf2(-/+) mice coincided with attenuated Cdkn2a promoter interactions involving HDAC3. HDAC3 knockdown in human colon cancer cells recapitulated the effects of SFN on p16 induction. Human subjects given a broccoli sprout extract supplement (200 μmol SFN equivalents), or reporting more than five cruciferous vegetable servings per week, had increased p16 expression that was inversely associated with HDAC3 in circulating peripheral blood mononuclear cells (PBMCs) and in biopsies obtained during screening colonoscopy.Nrf2 expression varies widely in both normal human colon and human colon cancers and likely contributes to the overall rate of tumor growth in the large intestine. It remains to be determined whether this influences global HDAC protein expression levels, as well as local HDAC interactions on genes dysregulated during human colon tumor development. If corroborated in future studies, Nrf2 status might serve as a biomarker of HDAC inhibitor efficacy in clinical trials using single agent or combination modalities to slow, halt, or regress the progression to later stages of solid tumors and hematological malignancies." @default.
• W2135991329 created "2016-06-24" @default.
• W2135991329 creator A5017964935 @default.
• W2135991329 creator A5025539155 @default.
• W2135991329 creator A5027475930 @default.
• W2135991329 creator A5058884417 @default.
• W2135991329 creator A5059987518 @default.
• W2135991329 creator A5067454062 @default.
• W2135991329 creator A5069848489 @default.
• W2135991329 creator A5077577650 @default.
• W2135991329 creator A5078951724 @default.
• W2135991329 creator A5082820494 @default.
• W2135991329 creator A5085287919 @default.
• W2135991329 creator A5086708085 @default.
• W2135991329 creator A5087776899 @default.
• W2135991329 date "2015-09-18" @default.
• W2135991329 modified "2023-10-17" @default.
• W2135991329 title "Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon" @default.
• W2135991329 cites W1592051611 @default.
• W2135991329 cites W1683287975 @default.
• W2135991329 cites W1924879152 @default.
• W2135991329 cites W1964320336 @default.
• W2135991329 cites W1967077010 @default.
• W2135991329 cites W1973023394 @default.
• W2135991329 cites W1991660464 @default.
• W2135991329 cites W1992763673 @default.
• W2135991329 cites W1997392910 @default.
• W2135991329 cites W2000465599 @default.
• W2135991329 cites W2002617822 @default.
• W2135991329 cites W2007900506 @default.
• W2135991329 cites W2016622416 @default.
• W2135991329 cites W2024473923 @default.
• W2135991329 cites W2025054234 @default.
• W2135991329 cites W2030749349 @default.
• W2135991329 cites W2031929350 @default.
• W2135991329 cites W2035532250 @default.
• W2135991329 cites W2038468771 @default.
• W2135991329 cites W2048832592 @default.
• W2135991329 cites W2048984423 @default.
• W2135991329 cites W2049823677 @default.
• W2135991329 cites W2057060764 @default.
• W2135991329 cites W2058520274 @default.
• W2135991329 cites W2066503677 @default.
• W2135991329 cites W2078441617 @default.
• W2135991329 cites W2079316438 @default.
• W2135991329 cites W2095327320 @default.
• W2135991329 cites W2096035514 @default.
• W2135991329 cites W2099474252 @default.
• W2135991329 cites W2105095164 @default.
• W2135991329 cites W2108389733 @default.
• W2135991329 cites W2122116064 @default.
• W2135991329 cites W2128428442 @default.
• W2135991329 cites W2129211848 @default.
• W2135991329 cites W2133190520 @default.
• W2135991329 cites W2141004419 @default.
• W2135991329 cites W2141265087 @default.
• W2135991329 cites W2144836619 @default.
• W2135991329 cites W2145224778 @default.
• W2135991329 cites W2147127562 @default.
• W2135991329 cites W2153601430 @default.
• W2135991329 cites W2154367294 @default.
• W2135991329 cites W2154384337 @default.
• W2135991329 cites W2154618092 @default.
• W2135991329 cites W2155696324 @default.
• W2135991329 cites W2157607726 @default.
• W2135991329 cites W2161737045 @default.
• W2135991329 cites W2165717337 @default.
• W2135991329 cites W2916083703 @default.
• W2135991329 doi "https://doi.org/10.1186/s13148-015-0132-y" @default.
• W2135991329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4575421" @default.
• W2135991329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26388957" @default.
• W2135991329 hasPublicationYear "2015" @default.
• W2135991329 type Work @default.
• W2135991329 sameAs 2135991329 @default.
• W2135991329 citedByCount "52" @default.
• W2135991329 countsByYear W21359913292016 @default.
• W2135991329 countsByYear W21359913292017 @default.
• W2135991329 countsByYear W21359913292018 @default.
• W2135991329 countsByYear W21359913292019 @default.
• W2135991329 countsByYear W21359913292020 @default.
• W2135991329 countsByYear W21359913292021 @default.
• W2135991329 countsByYear W21359913292022 @default.
• W2135991329 countsByYear W21359913292023 @default.
• W2135991329 crossrefType "journal-article" @default.
• W2135991329 hasAuthorship W2135991329A5017964935 @default.
• W2135991329 hasAuthorship W2135991329A5025539155 @default.
• W2135991329 hasAuthorship W2135991329A5027475930 @default.
• W2135991329 hasAuthorship W2135991329A5058884417 @default.
• W2135991329 hasAuthorship W2135991329A5059987518 @default.
• W2135991329 hasAuthorship W2135991329A5067454062 @default.
• W2135991329 hasAuthorship W2135991329A5069848489 @default.
• W2135991329 hasAuthorship W2135991329A5077577650 @default.
• W2135991329 hasAuthorship W2135991329A5078951724 @default.
• W2135991329 hasAuthorship W2135991329A5082820494 @default.
• W2135991329 hasAuthorship W2135991329A5085287919 @default.
• W2135991329 hasAuthorship W2135991329A5086708085 @default.
• W2135991329 hasAuthorship W2135991329A5087776899 @default.
• W2135991329 hasBestOaLocation W21359913291 @default.
• W2135991329 hasConcept C104317684 @default.
• W2135991329 hasConcept C119157956 @default.

• next